Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types.
about
Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for TherapyTranscription activator structure reveals redox control of a replication initiation reactionAPM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity.Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytesTransactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin.DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits.Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation.Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.The role of vaccines in the control of STDs: HPV vaccines.Anogenital warts and condom use--a survey of information giving.Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced diseaseAptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancerAdeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma lineThe expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder.HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective studyIncreased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteriGenetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.Cellular factors required for papillomavirus DNA replication.The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells.Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNAAssessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.Regression of papillomas induced by cottontail rabbit papillomavirus is associated with infiltration of CD8+ cells and persistence of viral DNA after regression.Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.Heterogeneity of Genetic Damage in Cervical Nuclei and Lymphocytes in Women with Different Levels of Dysplasia and Cancer-Associated Risk Factors.Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening roundsHuman papillomavirus type 18 is associated with less apoptosis in fibroblast tumours than human papillomavirus type 16.Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortalityp53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis.Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy.Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus.Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapingsHybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women.
P2860
Q26824925-CD419241-033F-4BD4-84F8-FAB578C48241Q27644700-9F37AA80-E7B0-4009-AEBD-7B9BFCE13294Q29977757-ECD98CAD-FBEF-4C73-8F6C-6A074F8DBAE0Q30452566-583C6222-0B83-4A75-A137-8B9000F8F412Q33782160-518A66D1-3F5D-438B-AF9B-27EF6F0822C4Q33784825-F0FF338F-CAF3-4328-9CB8-EAD3ECC09F2CQ33785841-B9450351-19F9-4CF3-A62B-A95DDD726AFDQ33805234-16690B1D-3EE7-4509-90A9-F24C9826B640Q33811834-2FAF812E-F7C0-42BD-A666-08401D10D3C2Q33839349-DD16EF5C-B0A0-474A-BE6B-85E86572155DQ33840918-46942B9B-355A-49B0-97AA-2E321B172CCAQ33936363-0020D4A6-3E90-493D-BFD7-158C397EF3F0Q33936680-10C2CB95-4176-4E77-9A03-0264A946DA40Q34046296-85E21B78-292F-4D0B-9EE2-D516950A6078Q34310582-4C144D58-4E9E-4C71-825C-8D8EA02908A3Q34344372-A79C9922-C1D6-45C3-9104-64B02CC46389Q34596772-1194DF24-CDC6-423B-8185-9E67DA3FD1F4Q34647795-F2CCDAD4-092A-4C31-A2AA-DF3D9EC790F6Q35154167-EA7613FB-1BA0-42F4-BA3D-F782D98629BAQ35587621-E07CA8B5-DD0F-4FBB-A4E5-35920058CDAEQ35761960-7CC2FC69-439B-415D-8F3E-320C28CB518BQ35782511-1AE493BB-20E3-4D76-A68A-8011466D5209Q35782743-2C839FDD-E896-474A-8104-3FD7170E6618Q35852375-C4B959B1-08FA-4149-A449-BBE6AD7C9367Q35857475-EE289D19-1A84-4C94-878E-3827F7655083Q35858861-2F34CC2D-D01C-4A5E-BA53-C8C0679946D3Q35860748-04D1A1AA-12F1-4B86-B4FB-A8AAA753FE64Q35867810-3BBADF64-B066-4605-B03C-942D3F11392FQ35888657-E8498191-803C-4A9B-A671-1253884D53BAQ35890718-05887808-69F0-4357-A894-3431C0BD8121Q35960300-7240401A-B4CF-4720-8DF2-C9AC6C8FE1D5Q36023019-BBFC7FF5-5D30-4220-826E-62EE54528B7AQ36081184-846E46D7-B8C2-4841-A0C9-13A65A6AE4E8Q36106455-752B9482-7F22-4E7D-80F0-C6E766BAF697Q36115243-3407ED9C-AFDB-4CCE-8D91-AE046208E1C5Q36116199-DA5C7E5A-28FD-4BFB-BD33-FDAC59F5B299Q36135340-D452FF5E-BE45-4C3C-A521-B2B051748959Q36431400-3413D013-C8BB-444A-8C1A-A677E2514143Q36543787-AEB9E802-50F1-4867-A88B-A8311C0DE65EQ36620436-59699603-F661-472B-9453-112806FFC7CC
P2860
Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Molecular pathogenesis of canc ...... ic human papillomavirus types.
@en
type
label
Molecular pathogenesis of canc ...... ic human papillomavirus types.
@en
prefLabel
Molecular pathogenesis of canc ...... ic human papillomavirus types.
@en
P1476
Molecular pathogenesis of canc ...... ic human papillomavirus types.
@en
P304
P577
1994-01-01T00:00:00Z